Immunomedics collaborates with GE Healthcare
Biopharmaceutical company Immunomedics Inc. said Wednesday it will work with GE Healthcare to evaluate an imaging agent that could be used in identifying cancers.
Immunomedics and GE Healthcare will collaborate to evaluate Immunomedics' method of attaching peptides to an imaging agent called F-18. Terms of the agreement were not disclosed, but Immunomedics said the General Electric Co. unit will cover all costs related to the collaboration.
Immunomedics and GE Healthcare will collaborate to evaluate Immunomedics' method of attaching peptides to an imaging agent called F-18. Terms of the agreement were not disclosed, but Immunomedics said the General Electric Co. unit will cover all costs related to the collaboration.
0 comments:
Post a Comment